U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896265) titled 'Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes' on Oct. 19.
Brief Summary: This study will test olatorepatide (study drug) to determine whether it can help treat overweight or obesity.
In this study we will test how safe and how well olatorepatide works compared to placebo in people who are overweight or obese but do not have diabetes.
The study is looking at:
* How well the study drug works
* How the body and blood and urine biomarkers change after taking the study drug, which can help researchers understand why the study drug may work better in some people than in others
* What side...